Webinar 4 (Part - 1) | Senolytics & In-Situ Exosomes – A Safer Regenerative Strategy
Thumbnail from YouTube. Playing loads the YouTube player.
History & recommendationsOff
Keep recently viewed content on this browser. Your history stays on this device and is never sent to Harbor. Videos you play can also help order related video recommendations.
Open saved items & history →About this video
Creator description · original language
Aging and degeneration do not begin with symptoms — they begin silently at the cellular level.
In Webinar 4, Dr. Capt Arvind Poswal explores a scientifically grounded regenerative approach combining senolytics with in-situ exosome activation, focusing on cellular cleanup before cellular stimulation.
This session explains why removing dysfunctional senescent cells is a critical prerequisite before attempting regenerative signaling, and how stimulating endogenous (self-derived) exosomes may offer a safer and more physiologically aligned alternative to externally sourced exosomes.
Key topics covered:
• Biology of senescent cells and inflammaging
• Why unchecked senescence limits regenerative outcomes
• Mechanism of senolytics in tissue rejuvenation
• In-situ exosome signaling vs exogenous exosome injections
• Safety, ethics, and clinical reasoning behind endogenous regeneration
• Practical insights for clinicians exploring regenerative medicine
This webinar is intended for doctors, researchers, and medically informed professionals interested in regenerative medicine, longevity science, and evidence-based innovation.
#Webinar4
#RegenerativeMedicine
#LongevityMedicine
#Senolytics
#Exosomes
#InSituExosomes
#CellularAging
#BiologicalAge
#Inflammaging
#EndogenousRegeneration
Dr. Arvind Poswal · 46 min · Source published: 2026-01-21
Added to Harbor: 10/22/2026
Original on YouTube ↗Automatically categorized source. Creator statements are not an independent evidence review or personal medical guidance.